Initial public offering of INIFY Laboratories on Euronext Growth, Oslo

$$BDO.LiveSite.Deals.DealType$$Capital Markets
$$BDO.LiveSite.Deals.ClientName$$INIFY Laboratories AB


BDO has provided financial due diligence in relation to INIFY Laboratories' listing on Euronext Growth.

Inify Laboratories provides cancer diagnostics through ultra-modern laboratory services within histopathology. Fully digital, standardised and AI- supported workflow is applied to optimise quality and response times, initially for prostate cancer.

The IPO date was 20 June 2022.

For further information, please contact us.